Pfizer | PFE

Stock Price
28.37
Daily Change
-0.10 -0.35%
Monthly
9.54%
Yearly
-23.65%
Q2 Forecast
25.31
Peers Price Chg Day Year Date
AbbVie 161.62 0.33 0.20% 10.25% May/14
Abbott 103.90 -0.93 -0.89% -5.41% May/14
ALKERMES 24.42 -0.29 -1.17% -21.23% May/14
Amgen 311.54 3.40 1.10% 33.40% May/14
AstraZeneca 12,246.00 -72.00 -0.58% 2.05% May/14
Bayer 29.22 -0.16 -0.54% -45.18% May/14
Biogen 227.15 1.80 0.80% -27.17% May/14
Bristol-Myers Squibb 44.72 -0.23 -0.51% -34.40% May/14
Catalent 55.51 -0.29 -0.51% 67.25% May/14
Gilead Sciences 67.70 0.16 0.24% -13.63% May/14
GlaxoSmithKline 1,810.00 0 0% 23.16% May/14
Glaxosmithkline 45.66 0.49 1.08% 24.14% May/14
J&J 151.44 0.21 0.14% -5.08% May/14
Eli Lilly 763.50 6.02 0.79% 75.72% May/14
Medtronic 84.36 0.74 0.89% -5.54% May/14
Merck 128.76 -0.66 -0.51% 10.65% May/14
Neurocrine Biosciences 138.48 2.33 1.71% 41.09% May/14
Novartis 93.49 0.42 0.45% 1.08% May/14
Novartis 103.35 1.12 1.09% 0.22% May/14
Prestige Brands 71.30 0.80 1.13% 21.59% May/14
Pacira 30.82 0.44 1.45% -27.43% May/14
Pfizer 28.37 -0.10 -0.35% -23.65% May/14
Perrigo 30.35 -0.53 -1.72% -11.35% May/14
Drreddys Laboratories 69.66 -0.22 -0.31% 25.97% May/14
Regeneron Pharmaceuticals 984.64 8.49 0.87% 31.12% May/14
Roche Holding 224.60 -3.00 -1.32% -20.99% May/14
Sanofi 91.69 -1.02 -1.10% -8.02% May/14
Sanofi 49.48 -0.74 -1.47% -9.28% May/14
Vertex Pharmaceuticals 428.05 -1.34 -0.31% 22.77% May/14
Zoetis 168.79 0.82 0.49% -8.19% May/14

Indexes Price Day Year Date
US500 5240 25.26 0.48% 27.51% May/15

Pfizer traded at $28.37 this Tuesday May 14th, decreasing $0.10 or 0.35 percent since the previous trading session. Looking back, over the last four weeks, Pfizer lost 9.54 percent. Over the last 12 months, its price fell by 23.65 percent. Looking ahead, we forecast Pfizer to be priced at 25.31 by the end of this quarter and at 24.34 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.